These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26340408)

  • 1. Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells.
    Hardege I; Xu S; Gordon RD; Thompson AJ; Figg N; Stowasser M; Murrell-Lagnado R; O'Shaughnessy KM
    Mol Endocrinol; 2015 Oct; 29(10):1522-30. PubMed ID: 26340408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
    Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
    Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.
    Murthy M; Azizan EA; Brown MJ; O'Shaughnessy KM
    J Hypertens; 2012 Sep; 30(9):1827-33. PubMed ID: 22743686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
    Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
    J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
    Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
    Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
    Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N
    J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
    Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
    Scholl UI; Nelson-Williams C; Yue P; Grekin R; Wyatt RJ; Dillon MJ; Couch R; Hammer LK; Harley FL; Farhi A; Wang WH; Lifton RP
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2533-8. PubMed ID: 22308486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
    Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
    Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
    Tauber P; Penton D; Stindl J; Humberg E; Tegtmeier I; Sterner C; Beuschlein F; Reincke M; Barhanin J; Bandulik S; Warth R
    Endocrinology; 2014 Apr; 155(4):1353-62. PubMed ID: 24506072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.